Clinical Trial Results:
A 12-week, open-label, parallel-cohort study to evaluate the efficacy, safety and tolerability of canakinumab in pediatric IVIG-naïve or refractory patients with active Kawasaki disease
Summary
|
|
EudraCT number |
2015-003763-11 |
Trial protocol |
IT BE DE NL PL |
Global completion date |
02 Jul 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v2(current) |
This version publication date |
02 Dec 2019
|
First version publication date |
01 May 2019
|
Other versions |
v1 |
Version creation reason |
|
Summary report(s) |
cancellation letter for CACZ885D2208 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.